Dec 11
Registration statement
S-4/A
Registration statement
BBIO · BridgeBio Pharma, Inc. · Documents
$78.30
+0.13 (+0.17%)
At close · Nov 13
Return incl. dividend (before tax)
Play latest call
Q3 2026 earnings call transcript
Market Cap
$15.25B
Shares
194.80M
Volume · Nov 13
1.15M
Avg daily vol (3M)
2.69M
You came from your AI assistant. Add Equibles to it and ask about this data directly, free.
The company's filings, earnings calls and investor events, most recent first. Search and read these filings from Claude or ChatGPT with the SEC filings MCP server →
2020
Nov 6
Current report
8-K
Charter or bylaw amendment, or fiscal year change
Nov 6
Registration statement
S-4
Registration statement
Nov 5
Current report
8-K
Financial results
Nov 5
Quarterly report
10-Q
FY2020 Q3, ended Sep 30
Quarterly report for FY2020 Q3
Revenue $8.13M
▼ 69.6%
Net loss $130.17M
Oct 23
Current report
8-K
Events of Oct 21
Director or officer change, or executive pay
Oct 6
Current report
8-K
Events of Oct 5
Entered into a material agreement
Oct 5
Current report
8-K
Other events
Sep 29
Current report
8-K
Regulation FD disclosure
Aug 11
Current report
8-K
Financial results
Aug 11
Jul 28
Registration statement
S-3ASR
Registration statement
Jul 7
Registration statement
S-3ASR
Registration statement
Jun 24
Current report
8-K
Events of Jun 23
Director or officer change, or executive pay, Regulation FD disclosure
Jun 8
Current report
8-K
Events of Jun 2
Director or officer change, or executive pay, Shareholder vote results
May 14
May 13
Current report
8-K
Financial results
Apr 29
Current report
8-K
Events of Apr 27
Entered into a material agreement, New debt or off-balance-sheet obligation
Apr 23
Proxy statement
DEFA14A
Proxy statement
Apr 22
Proxy statement
DEF 14A
Meeting Jun 2, 2020
Proxy statement
Mar 24
Current report
8-K
Other events
Mar 10
Current report
8-K
Events of Mar 4
Entered into a material agreement, New debt or off-balance-sheet obligation, Unregistered sale of equity, Other events
Mar 6
Current report
8-K
Events of Mar 4
Entered into a material agreement, New debt or off-balance-sheet obligation, Other events
Mar 4
Current report
8-K
Other events
Mar 3
Mar 2
Current report
8-K
Financial results
Feb 19
Current report
8-K
Events of Feb 12
Director or officer change, or executive pay
Jan 7
Current report
8-K
Events of Dec 31
Entered into a material agreement
Showing 151–178 of 178 documents
Key facts
CIK
1743881
CUSIP
10806X102
13F (30d)
355 filings
324 filers
Visit website
Investor relations